Tony T Kalajian's Net Worth
$17 Thousand
Who is Tony T Kalajian?
Tony T Kalajian does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncocyte Corp, and Calidi Biotherapeutics, Inc..
SEC CIK
Tony T Kalajian's CIK is 0001786237
Past Insider Trading and Trends
2020 was Tony T Kalajian's most active year for acquiring shares with 2 total transactions. Tony T Kalajian's most active month to acquire stocks was the month of January. 2019 saw Tony T Kalajian paying a total of $19,800.00 for 10,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Oncocyte Corp (OCX) Snapshot price: $2.89
Sr.VP/Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 5K |
$1.31 | $6,533.00 | 15K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
∞
| 10K |
$1.98 | $19,800.00 | 10K |
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Calidi Biotherapeutics, Inc. (CLDI) Snapshot price: $1.17
Chief Acctg Officer, Int. CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |